Amplification and attenuation of lung metastases depending on glucocorticoid dosage implicating long‐acting activated memory cells induced by nivolumab against malignant melanoma
Abstract Firstly, glucocorticoids such as prednisolone can attenuate the effect of anti–PD‐1 antibody nivolumab. Secondly, malignant melanoma cells survived latently and unnoticeably in places other than those of previous metastatic lesions. Thirdly, effector T cells activated by nivolumab sustained...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-09-01
|
Series: | Clinical Case Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/ccr3.2349 |
id |
doaj-268e9078312c4948b6faf833f982482b |
---|---|
record_format |
Article |
spelling |
doaj-268e9078312c4948b6faf833f982482b2020-11-24T21:11:28ZengWileyClinical Case Reports2050-09042019-09-01791709171310.1002/ccr3.2349Amplification and attenuation of lung metastases depending on glucocorticoid dosage implicating long‐acting activated memory cells induced by nivolumab against malignant melanomaKatsunori Katagiri0Kiyoto Shiga1Daisuke Saito2Shin‐ichi Oikawa3Aya Ikeda4Kodai Tsuchida5Jun Miyaguchi6Department of Head and Neck Surgery Iwate Medical University Morioka JapanDepartment of Head and Neck Surgery Iwate Medical University Morioka JapanDepartment of Head and Neck Surgery Iwate Medical University Morioka JapanDepartment of Head and Neck Surgery Iwate Medical University Morioka JapanDepartment of Head and Neck Surgery Iwate Medical University Morioka JapanDepartment of Head and Neck Surgery Iwate Medical University Morioka JapanDepartment of Head and Neck Surgery Iwate Medical University Morioka JapanAbstract Firstly, glucocorticoids such as prednisolone can attenuate the effect of anti–PD‐1 antibody nivolumab. Secondly, malignant melanoma cells survived latently and unnoticeably in places other than those of previous metastatic lesions. Thirdly, effector T cells activated by nivolumab sustained their memory to attack malignant melanoma cells for several months.https://doi.org/10.1002/ccr3.2349glucocorticoidsinterstitial pneumonitislung metastasismucosal malignant melanomanivolumab |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Katsunori Katagiri Kiyoto Shiga Daisuke Saito Shin‐ichi Oikawa Aya Ikeda Kodai Tsuchida Jun Miyaguchi |
spellingShingle |
Katsunori Katagiri Kiyoto Shiga Daisuke Saito Shin‐ichi Oikawa Aya Ikeda Kodai Tsuchida Jun Miyaguchi Amplification and attenuation of lung metastases depending on glucocorticoid dosage implicating long‐acting activated memory cells induced by nivolumab against malignant melanoma Clinical Case Reports glucocorticoids interstitial pneumonitis lung metastasis mucosal malignant melanoma nivolumab |
author_facet |
Katsunori Katagiri Kiyoto Shiga Daisuke Saito Shin‐ichi Oikawa Aya Ikeda Kodai Tsuchida Jun Miyaguchi |
author_sort |
Katsunori Katagiri |
title |
Amplification and attenuation of lung metastases depending on glucocorticoid dosage implicating long‐acting activated memory cells induced by nivolumab against malignant melanoma |
title_short |
Amplification and attenuation of lung metastases depending on glucocorticoid dosage implicating long‐acting activated memory cells induced by nivolumab against malignant melanoma |
title_full |
Amplification and attenuation of lung metastases depending on glucocorticoid dosage implicating long‐acting activated memory cells induced by nivolumab against malignant melanoma |
title_fullStr |
Amplification and attenuation of lung metastases depending on glucocorticoid dosage implicating long‐acting activated memory cells induced by nivolumab against malignant melanoma |
title_full_unstemmed |
Amplification and attenuation of lung metastases depending on glucocorticoid dosage implicating long‐acting activated memory cells induced by nivolumab against malignant melanoma |
title_sort |
amplification and attenuation of lung metastases depending on glucocorticoid dosage implicating long‐acting activated memory cells induced by nivolumab against malignant melanoma |
publisher |
Wiley |
series |
Clinical Case Reports |
issn |
2050-0904 |
publishDate |
2019-09-01 |
description |
Abstract Firstly, glucocorticoids such as prednisolone can attenuate the effect of anti–PD‐1 antibody nivolumab. Secondly, malignant melanoma cells survived latently and unnoticeably in places other than those of previous metastatic lesions. Thirdly, effector T cells activated by nivolumab sustained their memory to attack malignant melanoma cells for several months. |
topic |
glucocorticoids interstitial pneumonitis lung metastasis mucosal malignant melanoma nivolumab |
url |
https://doi.org/10.1002/ccr3.2349 |
work_keys_str_mv |
AT katsunorikatagiri amplificationandattenuationoflungmetastasesdependingonglucocorticoiddosageimplicatinglongactingactivatedmemorycellsinducedbynivolumabagainstmalignantmelanoma AT kiyotoshiga amplificationandattenuationoflungmetastasesdependingonglucocorticoiddosageimplicatinglongactingactivatedmemorycellsinducedbynivolumabagainstmalignantmelanoma AT daisukesaito amplificationandattenuationoflungmetastasesdependingonglucocorticoiddosageimplicatinglongactingactivatedmemorycellsinducedbynivolumabagainstmalignantmelanoma AT shinichioikawa amplificationandattenuationoflungmetastasesdependingonglucocorticoiddosageimplicatinglongactingactivatedmemorycellsinducedbynivolumabagainstmalignantmelanoma AT ayaikeda amplificationandattenuationoflungmetastasesdependingonglucocorticoiddosageimplicatinglongactingactivatedmemorycellsinducedbynivolumabagainstmalignantmelanoma AT kodaitsuchida amplificationandattenuationoflungmetastasesdependingonglucocorticoiddosageimplicatinglongactingactivatedmemorycellsinducedbynivolumabagainstmalignantmelanoma AT junmiyaguchi amplificationandattenuationoflungmetastasesdependingonglucocorticoiddosageimplicatinglongactingactivatedmemorycellsinducedbynivolumabagainstmalignantmelanoma |
_version_ |
1716753347068821504 |